2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Festive e-commerce sales hit Rs 24,000 crore in firs...
How to Balance Home Loan EMIs and Long-Term Investments
Self-Care Ideas for Mothers Who Rarely Get Time for ...
India's draft steel policy targets 604 million tonne...
Nifty may rally towards 23,300 above 22,800, Sensex ...
ADAS in Cars: Benefits and Limitations Explained
Quote on FPI flows 11th October 2026 from Dr. V K Vi...
Best Kitchen Gadgets That Save Time and Effort
Smart Packing Tips for Stress-Free Family Travel
Poonawalla Fincorp shares down nearly 16 pc in a year
